MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Nutrition and Dietary Assessment as a Wellness Factor in Parkinson’s Disease and Related Disorders

    N. Hellmers, B. Katz, M. Bruno, H. Sarva (New York, USA)

    Objective: To characterize nutrition and food related concerns identified during supportive care visits for individuals with Parkinson’s disease (PD) and related disorders. Background: Individuals with…
  • 2026 International Congress

    Chronic Vanadium Exposure Promotes Memory Impairment and Aggregation of Alpha-Synuclein, Tau and Amyloid Beta in Mouse Brain

    O. Folarin, F. Olopade, T. Gilbert, A. Ladagu, P. Inês, O. Mustapha, L. Zethan, J. Olopade, T. Outeiro (Ibadan, Nigeria)

    Objective: In this study, we hypothesized that prolonged vanadium exposure may be a potential risk factor for Alzheimer's and Parkinson's diseases. Background: The interaction between…
  • 2026 International Congress

    Real-World Mobile Voice Classification for Parkinson’s Disease Using Convolutional Neural Networks and Mel-Spectrogram Features

    N. Leabthong, J. Sringean, T. Laosombut, N. Jeh-Voh1, Z. Win, P. Rattanajun, S. Phumphid, C. Anan, J. Meesri, S. Wekhinhiran, O. Phokaewvarangkul, P. Panyakaew, S. Maytharakcheep, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the performance of deep learning approach based on Mel-spectrogram features in classifying PD using two real-world speech tasks - sustained phonation and…
  • 2026 International Congress

    Proposal of Anatomo-Functional Tremor Patterns for Ultrasound-Guided Botulinum Toxin Infiltration

    G. Salazar, I. Caballero (Terrassa, Spain)

    Objective: To propose a practical anatomo-functional framework for ultrasound-guided BoNT-A infiltration in upper limb tremor based on tremor biomechanics. Background: Botulinum toxin type A (BoNT-A)…
  • 2026 International Congress

    Urate Levels and Risk of Parkinson’s Disease:A Two-Sample Mendelian Randomization Study

    P. Tang, Y. Liu (Xi'an, China)

    Objective: To investigate the causal relationship between circulating serum urate levels and the risk of Parkinson's disease (PD) using a two-sample Mendelian randomization (MR) approach.…
  • 2026 International Congress

    The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the pharmacological and methodological factors underlying the "GLP-1 paradox" by comparing the outcomes of lixisenatide and exenatide, with an emphasis on kinetics,…
  • 2026 International Congress

    Early integrated Dysphagia and Nutritional Management in Parkinsonism: a prospective Feasibility Study to prevent Malnutrition and Complications

    Y. Zashchypas, S. Lorenzl (Salzburg, Austria)

    Objective: To assess feasibility, safety, adherence, and acceptability of an early integrated dysphagia–nutrition pathway for parkinsonism. Background: Dysphagia in parkinsonism may occur early and remain…
  • 2026 International Congress

    Community Gym Exercise Therapy for People Living with Early Onset Parkinson’s Disease

    C. Thwaites, M. Morris, D. Harris, M. Callisaya, R. Mouer, A. Clifford (Bundoora, Australia)

    Objective: To understand the experiences of people living with early onset Parkinson’s disease (EOPD) and exercise trainers regarding the safety, feasibility, acceptability and perceived benefits…
  • 2026 International Congress

    Changes in Continuous Good ON and Best ON Time During the Waking Day With Tavapadon in People With Parkinson’s Disease

    R. Hauser, R. Dhall, D. Kremens, L. Harmer, K. Chan, J. Ma (Tampa, USA)

    Objective: To evaluate motor states throughout the waking day when tavapadon is added to oral carbidopa/levodopa in adults with Parkinson’s disease (PD) experiencing motor fluctuations.…
  • 2026 International Congress

    Neurological Wilson’s disease: another form of tauopathies?

    XP. Wang (Shanghai, China)

    Objective: The authors would hope to identify distribution of Tau protein within the  brain of  Wilson's disease patients by tau-targeted positron emission tomography (PET) tracers Background:…
  • « Previous Page
  • 1
  • …
  • 102
  • 103
  • 104
  • 105
  • 106
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley